Annandale Capital, LLC - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Annandale Capital, LLC ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$14
-22.2%
40,0000.0%0.00%
-33.3%
Q4 2022$18
-99.9%
40,0000.0%0.01%
-53.8%
Q3 2022$35,00040,0000.01%
Other shareholders

There were no reported owners of LEAP THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of LEAP THERAPEUTICS INC shareholders